(Q36087036)

12 August 2017

1 reference

title

T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up! (English)

1 reference

12 August 2017

2

June CH

1 reference

12 August 2017

1

Porter DL

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Bone Marrow Transplantation

12 August 2017

published in

1 reference

12 August 2017

volume

35

1 reference

12 August 2017

issue

10

1 reference

12 August 2017

page(s)

935-942

1 reference

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Vaccination against infectious disease following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Persistence of memory CD8 T cells in MHC class I-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Population biology of lymphocytes: the flight for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

T cell homeostatic proliferation elicits effective antitumor autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

How much TCR does a T cell need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

A role for CaMKII in T cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Defective generation but normal maintenance of memory T cells in old mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Human T-cell clones in long-term culture as a model of immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Human naive and memory T lymphocytes differ in telomeric length and replicative potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Accelerated telomere shortening in response to life stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Will telomere erosion lead to a loss of T-cell memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Peripheral T cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Lymphocyte lifespans: homeostasis, selection and competition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Lifespan of human lymphocyte subsets defined by CD45 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Measurement of T-cell kinetics: recent methodologic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

In vivo estimates of division and death rates of human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Factors influencing T-cell turnover in HIV-1-seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Environmental conservation: bystander CD4 T cells keep CD8 memories fresh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Blood T-cell Vbeta transcriptome in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Cutting edge: Secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

CD28 activation promotes Th2 subset differentiation by human CD4+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Interleukin 7 worsens graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704953

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704953

1 reference

12 August 2017

1 reference